| COVID-19 Clinical Research Studies | Lifetime | 136 | CN 26 | 99.22 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 353 | CN 54 | 98.73 |
| Hepatitis B Virus Studies | Lifetime | 441 | CN 28 | 98.77 |
| COVID-19 epidemiological studies | Lifetime | 213 | CN 25 | 98.28 |
| Long-Term Effects of COVID-19 | Lifetime | 387 | CN 27 | 96.95 |
| COVID-19 Impact on Reproduction | Lifetime | 114 | CN 5 | 96.80 |
| Hepatitis C virus research | Lifetime | 617 | CN 23 | 98.34 |
| Traditional Chinese Medicine and Integrative Care | Lifetime | 151 | CN 104 | 94.31 |
| COVID-19 and Mental Health | Lifetime | 612 | CN 61 | 95.90 |
| Vaccine Coverage and Hesitancy | Lifetime | 682 | CN 23 | 96.07 |
| Hepatitis Viruses Studies and Epidemiology | Lifetime | 606 | CN 37 | 94.91 |
| Poxvirus research and outbreaks | Lifetime | 927 | CN 20 | 86.14 |
| Travel-related health issues | Lifetime | 871 | CN 17 | 79.27 |
| COVID-19 Clinical Research Studies | 2021-2025 | 56 | CN 7 | 99.60 |
| COVID-19 epidemiological studies | 2021-2025 | 20 | CN 6 | 99.23 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 145 | CN 24 | 99.30 |
| COVID-19 Impact on Reproduction | 2021-2025 | 23 | CN 3 | 98.30 |
| Hepatitis B Virus Studies | 2021-2025 | 46 | CN 10 | 98.91 |
| Health disparities and outcomes | 2021-2025 | 89 | CN 10 | 97.89 |
| Vaccine Coverage and Hesitancy | 2021-2025 | 101 | CN 8 | 98.08 |
| Global Maternal and Child Health | 2021-2025 | 155 | CN 6 | 97.67 |
| Pregnancy and preeclampsia studies | 2021-2025 | 153 | CN 18 | 97.23 |
| COVID-19 and Mental Health | 2021-2025 | 333 | CN 34 | 96.76 |
| Global Health Care Issues | 2021-2025 | 94 | CN 22 | 94.42 |
| Liver Disease Diagnosis and Treatment | 2021-2025 | 570 | CN 67 | 97.46 |
| Bacillus and Francisella bacterial research | 2021-2025 | 48 | CN 3 | 94.33 |
| Hepatitis C virus research | 2021-2025 | 167 | CN 15 | 97.10 |
| Mosquito-borne diseases and control | 2021-2025 | 282 | CN 14 | 95.81 |
| Long-Term Effects of COVID-19 | 2021-2025 | 604 | CN 21 | 94.93 |
| Poxvirus research and outbreaks | 2021-2025 | 66 | CN 4 | 94.33 |
| Hepatitis Viruses Studies and Epidemiology | 2021-2025 | 66 | CN 11 | 93.39 |
| Child Nutrition and Water Access | 2021-2025 | 368 | CN 5 | 94.20 |
| Healthcare Systems and Reforms | 2021-2025 | 155 | CN 17 | 93.11 |
| Climate Change and Health Impacts | 2021-2025 | 563 | CN 157 | 91.84 |
| Virology and Viral Diseases | 2021-2025 | 160 | CN 24 | 87.73 |
| Herpesvirus Infections and Treatments | 2021-2025 | 323 | CN 36 | 88.41 |
| Influenza Virus Research Studies | 2021-2025 | 467 | CN 69 | 90.80 |
| Tuberculosis Research and Epidemiology | 2021-2025 | 754 | CN 89 | 90.86 |
| Travel-related health issues | 2021-2025 | 55 | CN 4 | 87.66 |
| Pregnancy and Medication Impact | 2021-2025 | 299 | CN 14 | 87.47 |
| Pneumonia and Respiratory Infections | 2021-2025 | 963 | CN 58 | 86.43 |
| Viral Infections and Outbreaks Research | 2021-2025 | 520 | CN 41 | 84.98 |
| Malaria Research and Control | 2021-2025 | 935 | CN 27 | 86.20 |
| HIV-related health complications and treatments | 2021-2025 | 486 | CN 17 | 85.17 |
| Dental Health and Care Utilization | 2021-2025 | 740 | CN 48 | 85.20 |
| Global Public Health Policies and Epidemiology | 2021-2025 | 793 | CN 25 | 77.64 |
| Sex work and related issues | 2021-2025 | 523 | CN 9 | 79.15 |
| Pediatric health and respiratory diseases | 2021-2025 | 635 | CN 62 | 76.96 |
| Immune responses and vaccinations | 2021-2025 | 397 | CN 27 | 72.14 |
| Preterm Birth and Chorioamnionitis | 2021-2025 | 511 | CN 40 | 69.83 |
| Biological and pharmacological studies of plants | 2021-2025 | 292 | CN 239 | 63.64 |
| Data-Driven Disease Surveillance | 2021-2025 | 814 | CN 121 | 60.96 |
| Demographic Trends and Gender Preferences | 2021-2025 | 366 | CN 51 | 57.72 |
| Menopause: Health Impacts and Treatments | 2021-2025 | 762 | CN 36 | 52.73 |
